Hackensack Meridian Health to Pilot Combined Watson for Oncology and Cota Technology to Power Value-Based Clinical Decision Support in Cancer Care

Hackensack Meridian Health to Pilot Combined Watson for Oncology and Cota Technology to Power Value-Based Clinical Decision Support in Cancer Care

IBM Watson Health, Cota, and Hackensack Meridian Health, an integrated healthcare system in New Jersey, today announced a collaboration to pilot a combination of IBM Watson and Cota technology for the first time. The goal is to bring Cota’s value-based care and real-world data into IBM’s Watson for Oncology clinical decision support tool, which Hackensack Meridian Health oncologists will then use in a pilot to help inform patient care. The goal is ultimately to help oncologists make evidence- and outcomes-based clinical decisions for their cancer patients, which could reduce total cost of care.

#awvi,#watson,#ibm

IBM

via IBM Press Releases – All Topics – United States https://ibm.co/2cyz2Mh

June 2, 2017 at 04:03AM

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s